Administration of vaccine-boosted COVID-19 convalescent plasma to SARS-CoV-2 infected hamsters decreases virus replication in lungs and hastens resolution of the infection despite transiently enhancing disease and lung pathology

The utility of COVID-19 convalescent plasma (CCP) for treatment of immunocompromised patients who are not able to mount a protective antibody response against SARS-CoV-2 and who have contraindications or adverse effects from currently available antivirals remains unclear. To better understand the me...

Descripción completa

Detalles Bibliográficos
Autores principales: Carroll, Timothy D., Wong, Talia, Morris, Mary Kate, Di Germanio, Clara, Ma, Zhong-min, Stone, Mars, Ball, Erin, Fritts, Linda, Rustagi, Arjun, Simmons, Graham, Busch, Michael, Miller, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473650/
https://www.ncbi.nlm.nih.gov/pubmed/37662344
http://dx.doi.org/10.1101/2023.08.22.553458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473650/
https://www.ncbi.nlm.nih.gov/pubmed/37662344
http://dx.doi.org/10.1101/2023.08.22.553458

Ejemplares similares